{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:29:43Z","timestamp":1761060583139,"version":"3.41.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thespinejournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Spine Journal"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.spinee.2018.05.020","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T16:44:44Z","timestamp":1526921084000},"page":"1877-1887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6881-812X","authenticated-orcid":false,"given":"Young-Seok","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishab","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Taik","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Chul","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye Jin","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Young","family":"Seu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inbo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Heon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo-Kyung","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4867-6854","authenticated-orcid":false,"given":"Kyoung-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.spinee.2018.05.020_bib0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.spinee.2018.05.020_bib0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ejphar.2011.08.014","article-title":"Oral administration of quercetin inhibits bone loss in rat model of diabetic osteopenia","volume":"670","author":"Liang","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.spinee.2018.05.020_bib0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrendo.2011.233","article-title":"Bone, sweet bone\u2014osteoporotic fractures in diabetes mellitus","volume":"8","author":"Hamann","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.spinee.2018.05.020_bib0025","doi-asserted-by":"crossref","first-page":"820615","DOI":"10.1155\/2014\/820615","article-title":"Osteoporosis, fractures, and diabetes","volume":"2014","author":"Jackuliak","year":"2014","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.spinee.2018.05.020_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bone.2015.11.023","article-title":"The effects of strength training and raloxifene on bone health in aging ovariectomized rats","volume":"85","author":"Stringhetta-Garcia","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.spinee.2018.05.020_bib0035","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00701-012-1516-9","article-title":"A synergistic bone sparing effect of curcumin and alendronate in ovariectomized rat","volume":"154","author":"Cho","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.spinee.2018.05.020_bib0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.spinee.2015.08.061","article-title":"Effect of a selective estrogen receptor modulator on bone formation in osteoporotic spine fusion using an ovariectomized rat model","volume":"16","author":"Park","year":"2016","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2018.05.020_bib0045","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo","volume":"10","author":"Hughes","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.spinee.2018.05.020_bib0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jbmr.5650110203","article-title":"A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates","volume":"11","author":"Parfitt","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.spinee.2018.05.020_bib0055","first-page":"115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.spinee.2018.05.020_bib0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1359\/jbmr.2002.17.2.341","article-title":"Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women","volume":"17","author":"Ott","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.spinee.2018.05.020_bib0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00774-015-0733-8","article-title":"Preventive effects of raloxifene treatment on age-related weight loss in postmenopausal women","volume":"35","author":"Urano","year":"2017","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.spinee.2018.05.020_bib0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00774-013-0461-x","article-title":"The SERM raloxifene improves diaphyseal fracture healing in mice","volume":"31","author":"Spiro","year":"2013","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.spinee.2018.05.020_bib0075","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.spinee.2018.05.020_bib0080","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1600-0722.2010.00739.x","article-title":"The effect of diabetes mellitus on rat mandibular bone formation and microarchitecture","volume":"118","author":"Abbassy","year":"2010","journal-title":"Eur J Oral Sci"},{"key":"10.1016\/j.spinee.2018.05.020_bib0085","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.bone.2006.12.057","article-title":"Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress","volume":"40","author":"Hamada","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.spinee.2018.05.020_bib0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0169-6009(91)90124-I","article-title":"The ovariectomized rat model of postmenopausal bone loss","volume":"15","author":"Kalu","year":"1991","journal-title":"Bone Miner"},{"key":"10.1016\/j.spinee.2018.05.020_bib0095","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/jcp.24929","article-title":"Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation","volume":"230","author":"Coe","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.spinee.2018.05.020_bib0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/0471141755.ph0547s70","article-title":"Streptozotocin-induced diabetic models in mice and rats","volume":"70","author":"Furman","year":"2015","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.spinee.2018.05.020_bib0105","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bone.2012.02.005","article-title":"Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength","volume":"50","author":"Sakai","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.spinee.2018.05.020_bib0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejogrb.2009.09.001","article-title":"Effects of strontium ranelate, raloxifene and misoprostol on bone mineral density in ovariectomized rats","volume":"147","author":"Ahmet-Camcioglu","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.spinee.2018.05.020_bib0115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.spinee.2018.05.020_bib0120","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jdiacomp.2009.05.002","article-title":"Metformin reverses the deleterious effects of high glucose on osteoblast function","volume":"24","author":"Zhen","year":"2010","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.spinee.2018.05.020_bib0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/bonekey.2012.27","article-title":"Bone metabolism and fracture risk in type 2 diabetes mellitus","volume":"1","author":"Yamaguchi","year":"2012","journal-title":"Bonekey Rep"},{"key":"10.1016\/j.spinee.2018.05.020_bib0130","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/dme.12734","article-title":"Type 1 diabetes and risk of fracture: meta-analysis and review of the literature","volume":"32","author":"Shah","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.spinee.2018.05.020_bib0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S8756-3282(97)00220-2","article-title":"Growth-inhibitory effect of a high glucose concentration on osteoblast-like cells","volume":"22","author":"Terada","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.spinee.2018.05.020_bib0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/1097-4644(20001101)79:2<301::AID-JCB130>3.0.CO;2-0","article-title":"Extracellular glucose influences osteoblast differentiation and c-Jun expression","volume":"79","author":"Zayzafoon","year":"2000","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.spinee.2018.05.020_bib0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S8756-3282(00)00426-9","article-title":"Glucose-induced inhibition of in vitro bone mineralization","volume":"28","author":"Balint","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.spinee.2018.05.020_bib0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bone.2011.09.055","article-title":"Trabecular bone histomorphometry in humans with type 1 diabetes mellitus","volume":"50","author":"Armas","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.spinee.2018.05.020_bib0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bone.2015.02.019","article-title":"Biochemical bone turnover markers in diabetes mellitus\u2014a systematic review","volume":"82","author":"Starup-Linde","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.spinee.2018.05.020_bib0160","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.diabres.2013.03.007","article-title":"The effects of diabetes mellitus and diabetic nephropathy on bone and mineral metabolism in T2DM patients","volume":"100","author":"Chen","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.spinee.2018.05.020_bib0165","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0022-3565(24)38923-2","article-title":"Molecular mechanisms of selective estrogen receptor modulator (SERM) action","volume":"295","author":"Dutertre","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.spinee.2018.05.020_bib0170","first-page":"1879","article-title":"Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)","volume":"9","author":"Fujiwara","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.spinee.2018.05.020_bib0175","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00223-003-0069-6","article-title":"Improving metabolic control reverses the histomorphometric and biomechanical abnormalities of an experimentally induced bone defect in spontaneously diabetic rats","volume":"74","author":"Follak","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.spinee.2018.05.020_bib0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00418-007-0308-4","article-title":"Type I diabetic bone phenotype is location but not gender dependent","volume":"128","author":"Martin","year":"2007","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.spinee.2018.05.020_bib0185","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jcp.21608","article-title":"Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice","volume":"218","author":"Motyl","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.spinee.2018.05.020_bib0190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1902\/jop.2001.72.2.204","article-title":"Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: a randomized, placebo-controlled trial","volume":"72","author":"Rocha","year":"2001","journal-title":"J Periodontol"},{"key":"10.1016\/j.spinee.2018.05.020_bib0195","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/diacare.27.7.1547","article-title":"Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial","volume":"27","author":"Keegan","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.spinee.2018.05.020_bib0200","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00223-010-9450-4","article-title":"Are antiresorptive drugs effective against fractures in patients with diabetes?","volume":"88","author":"Vestergaard","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.spinee.2018.05.020_bib0205","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1359\/jbmr.040211","article-title":"Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study","volume":"19","author":"Johnell","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.spinee.2018.05.020_bib0210","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3340\/jkns.2013.54.6.461","article-title":"Therapeutic advantages of treatment of high-dose curcumin in the ovariectomized rat","volume":"54","author":"Cho","year":"2013","journal-title":"J Korean Neurosurg Soc"}],"container-title":["The Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943018302456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943018302456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T17:22:15Z","timestamp":1751649735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529943018302456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1529943018302456"],"URL":"https:\/\/doi.org\/10.1016\/j.spinee.2018.05.020","relation":{},"ISSN":["1529-9430"],"issn-type":[{"type":"print","value":"1529-9430"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model","name":"articletitle","label":"Article Title"},{"value":"The Spine Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spinee.2018.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}